본문 바로가기
KERD
논문KCI 등재

Human Herpesvirus 8–Unrelated Primary Effusion Lymphoma–Like Lymphoma in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류의학일반

초록

Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin’s lymphoma arising from a B-cell lineage characterized by the formation of malignant effusion in body cavities without evidence of a detectable tumor. The effusion contains tumor cells universally infected with human herpesvirus 8 (HHV8), which is the critical factor differentiating PEL from HHV8-unrelated PEL-like lymphoma (PEL-LL). This report describes a 77-year-old male patient with pleural effusion and ascites, containing lymphoma cells expressing a B-cell phenotype, but without markers of HHV8 in immunocytochemical analysis. The patient was diagnosed with PEL-LL and treated with six cycles of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP), which resulted in a complete remission. The patient is currently disease-free 15 months post-treatment. To the best of our knowledge, this is the first report on administration of R-CHOP in a PEL-LL patient in South Korea.

Abstract

Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin’s lymphoma arising from a B-cell lineage characterized by the formation of malignant effusion in body cavities without evidence of a detectable tumor. The effusion contains tumor cells universally infected with human herpesvirus 8 (HHV8), which is the critical factor differentiating PEL from HHV8-unrelated PEL-like lymphoma (PEL-LL). This report describes a 77-year-old male patient with pleural effusion and ascites, containing lymphoma cells expressing a B-cell phenotype, but without markers of HHV8 in immunocytochemical analysis. The patient was diagnosed with PEL-LL and treated with six cycles of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP), which resulted in a complete remission. The patient is currently disease-free 15 months post-treatment. To the best of our knowledge, this is the first report on administration of R-CHOP in a PEL-LL patient in South Korea.

참고문헌 (15)

  1. Chen YB, "Primary effusion lymphoma", Oncologist, 12, pp.569~576 (2007)
  2. Little RF, "HIV-associated non-Hodgkin lymphoma : incidence, presentation, and prognosis", JAMA, 285, pp.1880~1885 (2001)
  3. Wang HY, "Notch1 in primary effusion lymphoma : a clinicopathological study", Mod Pathol, 23, pp.773~780 (2010)
  4. Carbone A, "PEL and HHV8-unrelated effusion lymphomas : classification and diagnosis", Cancer, 114, pp.225~227 (2008)
  5. Alexanian S, "KSHV", HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states, 2013, pp.37, 241~249
  6. Mohammad F, "A unique case of malignant pleuropericardial effusion : HHV-8-unrelated PEL-like lymphoma : a case report and review of the literature", Case Rep Oncol Med, 2014, pp.436821~ (2014)
  7. Fan HB, "Human herpes virus 8-unrelated primary effusion lymphomalike lymphoma in a patient with hepatitis B virus-related liver cirrhosis : a case report", J Res Med Sci, 19, pp.190~192 (2014)
  8. Kashiwagi T, "HIV-negative, HHV-8-unrelated primary effusion lymphoma-like lymphoma with genotypic infidelity and c-MYC expression", Ann Hematol, 93, pp.1609~1610 (2014)
  9. Nador RG, "Primary effusion lymphoma : a distinct clinicopathologic entity associated with the Kaposi's sarcomaassociated herpes virus", Blood, 88, pp.645~656 (1996)
  10. Okada S, "Current status of treatment for primary effusion lymphoma", Intractable Rare Dis Res, 3, pp.65~74 (2014)
  11. Castillo JJ, "Prognosis in primary effusion lymphoma is associated with the number of body cavities involved", Leuk Lymphoma, 53, pp.2378~2382 (2012)
  12. Toyoda K, "Successful treatment with oral low-dose sobuzoxane and etoposide combined with rituximab in an elderly patient with HHV-8-negative primary effusion lymphoma-like lymphoma", Rinsho Ketsueki, 55, pp.815~819 (2014)
  13. Wu W, "Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma : report of a rare case and review of 54 cases in the literature", Am J Clin Pathol, 140, pp.258~273 (2013)
  14. Wu W, "Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma diagnosed by fluorodeoxyglucose positron emission tomography", computer tomography and laparoscopy, 2014, pp.7, 433~434
  15. Kyung Ho Kim, "A Case of Human Herpes Virus-8 Unrelated Primary Effusion Lymphoma-Like Lymphoma Presented as Pleural Effusion", Tuberculosis and Respiratory Diseases, 73(6), pp.336~341 (2012), 대한결핵및호흡기학회

관련 논문AI추천

Body Cavity–Based Lymphoma in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of Lymphoma박용, 고영일, 고영혜, 김석진, 김원석, 김진석, 신정훈, 신호진, 오성용, 원종호, 윤덕현, 윤성수, 이정옥대한암학회 · Cancer Research and Treatment2019 · 제51권 제4호Current Concepts in Primary Effusion Lymphoma and Other Effusion-Based Lymphomas노진, 김윤정, 박찬정, 허주령대한병리학회 · Journal of Pathology and Translational Medicine2014 · 제48권 제2호Primary Effusion Lymphoma: An Untrivial Differential Diagnosis for AscitesFunda Ceran, Levent Özçakar, Mehmet YIldIz, Ünsal Han, Yusuf AydIn연세대학교의과대학 · Yonsei Medical Journal2009 · 제50권 제6호알코올 간경화 환자에서 진단된 일차성 삼출 림프종 1예강병욱, 강윤구, 류민희, 박찬정, 심선진, 조재철, 최지영대한내과학회 · 대한내과학회지2008 · 제75권 제3호만성 신질환 환자에서 발생한 원발성 삼출액 림프종 1예김미연, 김현우, 유정래, 이재천, 정우성, 한상훈, 현창림대한내과학회 · 대한내과학회지2012 · 제83권 제3호Human Herpesvirus 8-Negative and Epstein-Barr Virus-Positive Effusion-Based Lymphoma in a Patient with Human Immunodeficiency Virus김영식, 김영혜, 이주한, 최정우대한병리학회 · Journal of Pathology and Translational Medicine2015 · 제49권 제5호

이 간행물의 다른 논문 (29건)